Search

David W. Berke-schlessel

Examiner (ID: 6754, Phone: (571)270-3643 , Office: P/1651 )

Most Active Art Unit
1651
Art Unit(s)
1651, 1799
Total Applications
867
Issued Applications
517
Pending Applications
104
Abandoned Applications
260

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20577567 [patent_doc_number] => 12569806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-10 [patent_title] => Devices, methods, and systems for capturing and sequestering atmospheric gases [patent_app_type] => utility [patent_app_number] => 19/244168 [patent_app_country] => US [patent_app_date] => 2025-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 0 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19244168 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/244168
Devices, methods, and systems for capturing and sequestering atmospheric gases Jun 19, 2025 Issued
Array ( [id] => 20277672 [patent_doc_number] => 20250302914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-02 [patent_title] => ELECTROPORATION-TARGETED DELIVERY OF RIBOSOME INACTIVATING PROTEIN GELONIN INTO MAMMALIAN CELLS [patent_app_type] => utility [patent_app_number] => 19/089650 [patent_app_country] => US [patent_app_date] => 2025-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2311 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19089650 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/089650
Electroporation-targeted delivery of ribosome inactivating protein gelonin into mammalian cells Mar 24, 2025 Issued
Array ( [id] => 19641379 [patent_doc_number] => 20240415899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-19 [patent_title] => BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS [patent_app_type] => utility [patent_app_number] => 18/820753 [patent_app_country] => US [patent_app_date] => 2024-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12402 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18820753 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/820753
Bacteriotherapy for clostridium difficile colitis Aug 29, 2024 Issued
Array ( [id] => 20568736 [patent_doc_number] => 20260062657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-03-05 [patent_title] => METHOD AND SYSTEM FOR MITIGATING GREENHOUSE GAS EMISSIONS BY PROMOTING THE GROWTH OF METHANE-OXIDIZING BACTERIA [patent_app_type] => utility [patent_app_number] => 18/818581 [patent_app_country] => US [patent_app_date] => 2024-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2482 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18818581 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/818581
METHOD AND SYSTEM FOR MITIGATING GREENHOUSE GAS EMISSIONS BY PROMOTING THE GROWTH OF METHANE-OXIDIZING BACTERIA Aug 27, 2024 Pending
Array ( [id] => 19570368 [patent_doc_number] => 20240374660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => Bifidobacterium longum CCFM1206 capable of producing sulforaphane and relieving inflammation [patent_app_type] => utility [patent_app_number] => 18/780491 [patent_app_country] => US [patent_app_date] => 2024-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7137 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18780491 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/780491
Bifidobacterium longum CCFM1206 capable of producing sulforaphane and relieving inflammation Jul 22, 2024 Pending
Array ( [id] => 19860731 [patent_doc_number] => 20250099517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => Use of Lactobacillus reuteri Y7 strain for prevention or treatment of ocular diseases [patent_app_type] => utility [patent_app_number] => 18/774556 [patent_app_country] => US [patent_app_date] => 2024-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7920 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774556 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/774556
Use of Lactobacillus reuteri Y7 strain for prevention or treatment of ocular diseases Jul 15, 2024 Pending
Array ( [id] => 19691275 [patent_doc_number] => 20250009820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => WOMEN'S HEALTH PROBIOTIC FORMULATIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/763204 [patent_app_country] => US [patent_app_date] => 2024-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6091 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18763204 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/763204
WOMEN'S HEALTH PROBIOTIC FORMULATIONS AND METHODS OF USE THEREOF Jul 2, 2024 Pending
Array ( [id] => 19657104 [patent_doc_number] => 20240424169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => CROSSLINKED SOFT TISSUE GRAFT AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/757079 [patent_app_country] => US [patent_app_date] => 2024-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2872 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18757079 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/757079
CROSSLINKED SOFT TISSUE GRAFT AND METHODS OF USE THEREOF Jun 26, 2024 Pending
Array ( [id] => 19432338 [patent_doc_number] => 20240300836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => COMPOSITION WITH A TIME RELEASE MATERIAL FOR REMOVING HALOGENATED HYDROCARBONS FROM CONTAMINATED ENVIRONMENTS [patent_app_type] => utility [patent_app_number] => 18/667427 [patent_app_country] => US [patent_app_date] => 2024-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12482 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18667427 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/667427
COMPOSITION WITH A TIME RELEASE MATERIAL FOR REMOVING HALOGENATED HYDROCARBONS FROM CONTAMINATED ENVIRONMENTS May 16, 2024 Pending
Array ( [id] => 19556779 [patent_doc_number] => 20240368571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => EUBACTERIUM RECTALE CAS12A MUTANTS [patent_app_type] => utility [patent_app_number] => 18/647516 [patent_app_country] => US [patent_app_date] => 2024-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57250 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18647516 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/647516
EUBACTERIUM RECTALE CAS12A MUTANTS Apr 25, 2024 Pending
Array ( [id] => 19862590 [patent_doc_number] => 20250101376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => METHODS FOR FORMING THREE-DIMENSIONAL HUMAN RETINAL TISSUE IN VITRO [patent_app_type] => utility [patent_app_number] => 18/644764 [patent_app_country] => US [patent_app_date] => 2024-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8946 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18644764 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/644764
METHODS FOR FORMING THREE-DIMENSIONAL HUMAN RETINAL TISSUE IN VITRO Apr 23, 2024 Pending
Array ( [id] => 19528511 [patent_doc_number] => 20240352413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => ISOLATED HUMAN LUNG PROGENITOR CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/639238 [patent_app_country] => US [patent_app_date] => 2024-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38950 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639238 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/639238
ISOLATED HUMAN LUNG PROGENITOR CELLS AND USES THEREOF Apr 17, 2024 Pending
Array ( [id] => 20013825 [patent_doc_number] => 20250152047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-15 [patent_title] => MEDICAL DIAGNOSTIC DEVICES AND METHODS [patent_app_type] => utility [patent_app_number] => 18/639358 [patent_app_country] => US [patent_app_date] => 2024-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639358 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/639358
MEDICAL DIAGNOSTIC DEVICES AND METHODS Apr 17, 2024 Pending
Array ( [id] => 19528504 [patent_doc_number] => 20240352406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => BIOCOMPATIBLE CONDITIONED CELL MEDIUM COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/639518 [patent_app_country] => US [patent_app_date] => 2024-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17541 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639518 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/639518
Biocompatible conditioned cell medium compositions and uses thereof Apr 17, 2024 Issued
Array ( [id] => 19343593 [patent_doc_number] => 20240252556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS [patent_app_type] => utility [patent_app_number] => 18/631959 [patent_app_country] => US [patent_app_date] => 2024-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12402 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18631959 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/631959
Bacteriotherapy for clostridium difficile colitis Apr 9, 2024 Issued
Array ( [id] => 19345486 [patent_doc_number] => 20240254449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => SYSTEMS AND METHODS FOR GROWTH OF INTESTINAL CELLS IN MICROFLUIDIC DEVICES [patent_app_type] => utility [patent_app_number] => 18/626855 [patent_app_country] => US [patent_app_date] => 2024-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37280 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18626855 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/626855
Systems and methods for growth of intestinal cells in microfluidic devices Apr 3, 2024 Issued
Array ( [id] => 19433857 [patent_doc_number] => 20240302355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => METHOD AND SYSTEM FOR DETERMINING INTEGRATED METABOLIC BASELINE AND POTENTIAL OF LIVING CELLS [patent_app_type] => utility [patent_app_number] => 18/609912 [patent_app_country] => US [patent_app_date] => 2024-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7419 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609912 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/609912
METHOD AND SYSTEM FOR DETERMINING INTEGRATED METABOLIC BASELINE AND POTENTIAL OF LIVING CELLS Mar 18, 2024 Pending
Array ( [id] => 19418378 [patent_doc_number] => 20240294501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => ISLET CELL MANUFACTURING COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/581700 [patent_app_country] => US [patent_app_date] => 2024-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44232 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581700 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/581700
Islet cell manufacturing compositions and methods of use Feb 19, 2024 Issued
Array ( [id] => 19447236 [patent_doc_number] => 20240307366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY [patent_app_type] => utility [patent_app_number] => 18/581245 [patent_app_country] => US [patent_app_date] => 2024-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36875 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581245 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/581245
Use of HSP70 as a regulator of enzymatic activity Feb 18, 2024 Issued
Array ( [id] => 20793913 [patent_doc_number] => 20260174807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-06-25 [patent_title] => PRODUCT FOR PREVENTING AND/OR TREATING OBESITY AND METABOLIC SYNDROME, METHOD OF PREPARATION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/832215 [patent_app_country] => US [patent_app_date] => 2024-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4138 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18832215 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/832215
PRODUCT FOR PREVENTING AND/OR TREATING OBESITY AND METABOLIC SYNDROME, METHOD OF PREPARATION AND USE THEREOF Feb 17, 2024 Pending
Menu